Health

LifeTech Reports Steady Growth of 32.5percent in Net Profit Attributable to Owners of the Company in 2022

SHENZHEN, China, March 29, 2023 /PRNewswire/ -- LifeTech Scientific Corporation (the "Company" or "Lifetech"), a leading company specialized in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, today announced its 2022 annual results. ...

2023-03-29 22:21 3193

bitBiome and Kaken Pharmaceuticals sign joint research agreement on the discovery of drugs for infectious diseases

-The joint research will use bitBiome's drug discovery platform technology to search for drug candidate substances- TOKYO, March 29, 2023 /PRNewswire/ -- bitBiome, Inc. (Head office: Shinjuku-ku,Tokyo; President: Yuji Suzuki; hereafter 'bitBiome') and Kaken Pharmaceuticals (Head office: Bunkyo-k...

2023-03-29 22:00 1980

CHINA LIFE INSURANCE COMPANY LIMITED ANNOUNCES 2022 ANNUAL RESULTS (H SHARES)

HONG KONG, March 29, 2023 /PRNewswire/ -- China Life Insurance Company Limited (SSE: 601628, SEHK: 2628) announces the audited consolidated results of the Company (China Life Insurance Company Limited and its subsidiaries) for the year ended31 December 2022 (the "Reporting Period") prepared under...

2023-03-29 21:22 2700

Scivita Medical enters into Strategic Agreement with Boston Scientific in China

SUZHOU, China, March 29, 2023 /PRNewswire/ -- Medical technology company Scivita Medical Technology Co., Ltd. ('Scivita Medical') and Boston Scientific (NYSE: BSX), one of the leading medical technology companies worldwide, have officially signed aStrategic Agreement for Scivita's Single-Use Perc...

2023-03-29 21:08 1556

Just Three Months Into 2023, United Imaging Says Four New Scanners in Multiple Imaging Modalities Are Now Commercially Available in the United States

The products expand the company's success in outpatient imaging and bring new benefits to the acute care and academic segments. HOUSTON, March 29, 2023 /PRNewswire/ -- United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, announced that four new sc...

2023-03-29 21:00 1379

HanAll Biopharma Assigns Su-jin Park as Co-CEO to Drive Next Phase of Growth

* Su-jin Park joins HanAll Biopharma in a shared leadership role to strengthen pharmaceutical business in Korea, supporting growth in domestic drug sales * Sean Jeong, who has been serving as Co-CEO since March 2021, will continue to lead HanAll's R&D, including its subsidiary HanAll Pharmace...

2023-03-29 19:00 1428

BGI Genomics Partners with Zentya to Launch Fecal DNA Test for Colorectal Cancer in Slovakia

BRATISLAVA, Slovakia, March 29, 2023 /PRNewswire/ -- BGI Genomics is pleased to announce the launch of COLOTECTTM 1.0 in Slovakia, in collaboration with its partner, Zentya. Zentya is a Slovak-based company that is passionate about providing patients with the latest technology in genetic screenin...

2023-03-29 16:00 1331

Fosun Pharma Announces its 15th Corporate Social Responsibility Report: Continuous Innovation for the Benefit of the Public

SHANGHAI, March 29, 2023 /PRNewswire/ -- On March 27, 2023, the release date of its 2022 Annual Report, Fosun Pharma (stock code: 600196.SH; 02196.HK) also released the2022 Corporate Social Responsibility Report, its 15th CSR report since the first which was issued in 2009. As before, Fosun Pharm...

2023-03-29 14:06 1705

Transcenta's Osemitamab (TST001) Targeting Claudin18.2 Granted Orphan Drug Designation for Treatment of Pancreatic Cancer

SUZHOU, China, March 29, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics,announces that the U.S. Food an...

2023-03-29 14:00 3090

People in Asia seek to extend health span for longer, healthier retirement, Manulife survey shows

* Survey of 7,000+ people in Asia shows expectation of early retirement, early deterioration in health * Concerns about cost of well-being nudging people towards DIY healthcare using mobile apps * Optimism about achieving financial goals and retirement savings targets in the next 5-10 years...

2023-03-29 11:00 2780

Antengene Announces First Patient Dosed with Claudin 18.2 Antibody-Drug Conjugate ATG-022 for the Treatment of Patients with Advanced or Metastatic Solid Tumors in Australia

* Discovered and developed in-house by Antengene's R&D team, ATG-022 is an antibody-drug-conjugate (ADC) targeting the Tumor Associated Antigen (TAA) Claudin 18.2. * The Phase I CLINCH trial is designed to evaluate the safety, pharmacology, and preliminary efficacy of ATG-022 monotherapy in p...

2023-03-29 08:30 2380

Innovent Announces 2022 Annual Results and Business Updates

Building an Innovative Biopharmaceutical Company with Sustainable Growth and Comprehensive Capability ROCKVILLE, Md. and SUZHOU, China, March 29, 2023 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commer...

2023-03-29 08:00 3222

Verbal Beginnings partners with The Clinician to launch a Patient Reported Outcomes Program for Children with Autism Spectrum Disorder

COLUMBIA, Md., March 29, 2023 /PRNewswire/ -- A leading US-based Applied Behavior Analysis (ABA) therapy provider , Verbal Beginnings, has partnered with The Clinician, a global healthcare company, to pilot a patient reported outcome measures (PROMs) program for...

2023-03-29 02:32 1854

AliExpress Signs Product Safety Pledge+ at the European Consumer Summit 2023

Elevating its voluntary commitment on product compliance for a fair, regulated online marketplace BRUSSELS, March 28, 2023 /PRNewswire/ -- AliExpress, a global retail online marketplace part of Alibaba Group, today signed the EU's Product Safety Pledge+, a voluntary commitment facilitated by the...

2023-03-28 22:00 1671

Healthcare Revolution: Medical Tourism and the American Dream

PALM BEACH GARDENS, Fla., March 28, 2023 /PRNewswire/ -- The 15th annual Healthcare Revolution (May 23, 2023), the largest confluence of thought leaders in the world of healthcare, self-funded employers, brokers, and healthcare leaders, has launched, and this time with thought-provoking and insig...

2023-03-28 21:53 2075

Kintor Pharma Announces Completion of Subject Enrollment in Phase III Clinical Trial of KX-826 for Treatment of Male Androgenetic Alopecia in China

SUZHOU, China, March 28, 2023 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, announced that the company has completed the enrollment of 740 subjects recently for...

2023-03-28 21:41 1565

Antengene Announces Results for Full Year 2022 with Updates Highlighting a Sales Revenue Reaching 5.6 Times Year-Over-Year and Accelerated Global Innovation

SHANGHAI and HONG KONG, March 28, 2023 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), today announced its full-year 2022 financial results and provided updates on key events and achievements since the start of 2022. 1. Sales Revenue Reached 5.6 Times Year-Over-Year ...

2023-03-28 21:40 2416

BIMINI HEALTH TECH ACQUIRES EXCLUSIVE LICENSE TO ACELLULAR DERMAL MATRIX PRODUCT PORTFOLIO

Acquisition expands Bimini's global soft tissue franchise, which already includes the PureGraft and Dermapose Fat Transfer Systems PLANO, Texas, March 28, 2023 /PRNewswire/ -- Bimini Health Tech announced today it has acquired the exclusive rights to an Acellular Dermal Matrix ("ADM") technology...

2023-03-28 21:20 1550

New Study Reveals Clinical Instability Predicts Psychiatric Hospitalization

First study of its kind, based on real-world data from Holmusk's NeuroBlu Database, shows patients who score highest for severity and instability were 45% more likely to be hospitalized NEW YORK, March 28, 2023 /PRNewswire/ -- For patients with psychiatric conditions, illness severity and i...

2023-03-28 21:00 2015

Pulnovo Medical Announces 3-Year Follow-up Results from PADN-5 at THT 2023, The Medical Device Maker Breaks New Ground in Heart Failure Treatment

SHANGHAI, March 28, 2023 /PRNewswire/ -- Pulnovo Medical Limited, a globally recognized OTM platform, announced the results from its PADN series study during the Late-Breaking Clinical Science (LBCS) session of the  second Technology and Heart Failure Therapeutics (THT 2023), with the presentatio...

2023-03-28 20:30 1690
1 ... 249250251252253254255 ... 848